Risk of morbidity in contemporary celiac disease

Nina R Lewis1, Geoffrey K T Holmes

  • 1Division of Epidemiology and Public Health, University of Nottingham, UK.

Insights

Celiac disease (an autoimmune disorder) affects about 1% of Western populations. Recognizing its common comorbidities, like autoimmune diseases and liver disorders, is crucial for accurate diagnosis and management.

Area of Science:

  • Gastroenterology
  • Immunology
  • Epidemiology

Background:

  • Celiac disease is a prevalent chronic disorder in Western countries, affecting approximately 1% of the population.
  • Its high prevalence necessitates understanding associated comorbidities, which can arise as chance associations, complications, or true links.

Purpose of the Study:

  • To provide reliable epidemiological data on the frequency of comorbidities associated with celiac disease.
  • To differentiate between true associations and coincidental occurrences, and to clarify the risks of complications.

Main Methods:

  • Review of recent epidemiological studies designed to minimize bias from patient selection and control groups.
  • Analysis of data to establish the frequency of various comorbidities and complications.

Main Results:

  • Autoimmune diseases (Type 1 diabetes, thyroid disorders) and liver conditions (primary biliary cirrhosis, primary sclerosing cholangitis) are significant associations.
  • Malignant complications, particularly lymphoma, show a modest increase (approx. fivefold), but the absolute numbers are small. Fracture risk increase is also modest.
  • No specific neurological or psychiatric disorders are definitively linked, and reproductive issues appear overexaggerated.

Conclusions:

  • Accurate recognition of celiac disease comorbidities is essential to avoid misattributing symptoms to gluten exposure and to ensure timely diagnosis of secondary conditions.
  • Undetected celiac disease may result if its symptoms are falsely assumed to explain the entire clinical picture.

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...